X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BATA INDIA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BATA INDIA - Comparison Results

BATA INDIA 
   Change

Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BATA INDIA AMAR REMEDIES/
BATA INDIA
 
P/E (TTM) x -0.5 64.2 - View Chart
P/BV x 0.1 8.6 0.7% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   BATA INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BATA INDIA
Mar-16
AMAR REMEDIES/
BATA INDIA
5-Yr Chart
Click to enlarge
High Rs164622 26.4%   
Low Rs86438 19.6%   
Sales per share (Unadj.) Rs261.6377.4 69.3%  
Earnings per share (Unadj.) Rs17.434.0 51.1%  
Cash flow per share (Unadj.) Rs22.345.7 48.7%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs100.7183.9 54.8%  
Shares outstanding (eoy) m26.1664.26 40.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.51.4 34.0%   
Avg P/E ratio x7.215.6 46.1%  
P/CF ratio (eoy) x5.611.6 48.4%  
Price / Book Value ratio x1.22.9 43.1%  
Dividend payout %010.3 0.0%   
Avg Mkt Cap Rs m3,27034,064 9.6%   
No. of employees `000NA4.8 0.0%   
Total wages/salary Rs m1632,633 6.2%   
Avg. sales/employee Rs ThNM5,057.0-  
Avg. wages/employee Rs ThNM548.9-  
Avg. net profit/employee Rs ThNM455.7-  
INCOME DATA
Net Sales Rs m6,84424,254 28.2%  
Other income Rs m21300 7.0%   
Total revenues Rs m6,86524,553 28.0%   
Gross profit Rs m1,1312,706 41.8%  
Depreciation Rs m128753 17.0%   
Interest Rs m39817 2,314.0%   
Profit before tax Rs m6262,236 28.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50747 -6.7%   
Tax Rs m121798 15.2%   
Profit after tax Rs m4552,185 20.8%  
Gross profit margin %16.511.2 148.1%  
Effective tax rate %19.335.7 54.2%   
Net profit margin %6.69.0 73.8%  
BALANCE SHEET DATA
Current assets Rs m4,90411,512 42.6%   
Current liabilities Rs m3,5814,644 77.1%   
Net working cap to sales %19.328.3 68.3%  
Current ratio x1.42.5 55.2%  
Inventory Days Days124103 120.5%  
Debtors Days Days10011 937.4%  
Net fixed assets Rs m1,6893,231 52.3%   
Share capital Rs m262643 40.8%   
"Free" reserves Rs m2,35810,908 21.6%   
Net worth Rs m2,63511,819 22.3%   
Long term debt Rs m5070-   
Total assets Rs m6,86217,491 39.2%  
Interest coverage x2.6131.0 2.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 71.9%   
Return on assets %12.412.6 98.7%  
Return on equity %17.318.5 93.4%  
Return on capital %31.025.4 122.1%  
Exports to sales %4.00.6 692.5%   
Imports to sales %05.4 0.0%   
Exports (fob) Rs m273140 195.4%   
Imports (cif) Rs mNA1,298 0.0%   
Fx inflow Rs m273140 195.4%   
Fx outflow Rs m22,055 0.1%   
Net fx Rs m271-1,916 -14.1%   
CASH FLOW
From Operations Rs m-3132,055 -15.2%  
From Investments Rs m-489-1,162 42.0%  
From Financial Activity Rs m769-519 -148.1%  
Net Cashflow Rs m-33375 -8.7%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 53.0 -  
Indian inst/Mut Fund % 9.2 9.8 93.9%  
FIIs % 0.0 20.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 17.1 381.9%  
Shareholders   13,061 83,621 15.6%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   HIND. UNILEVER  P&G HYGIENE  LINC PEN & PLASTICS LTD  GODREJ INDUSTRIES  COLGATE  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends in Red on Diwali Day; Bank & Metal Stocks Fall(Closing)

The hour-long auspicious Muhurat trading session ended on a weak note today. While the BSE Sensex closed lower by about 194 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

25 Things PM Modi Did Not Tell You About the Indian Economy(Vivek Kaul's Diary)

Oct 9, 2017

There are way too many data points out there which clearly show that all is not well with the Indian economy.

Electric Vehicles Boom: Stocks to Watch Out For(Smart Contrarian)

Oct 9, 2017

Are you creating a watch list of stocks for participating in the coming electric vehicles boom?

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

9 Common, Yet Vital Questions On Personal Finance Answered(Outside View)

Oct 13, 2017

The answers to these 9 questions act as thumb rules to streamline your personal finances.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS